• UP NEXT

    Try These Tips for Staying Healthy During the Holiday Season

    04:28
  • Barry Manilow Reveals Lung Cancer Diagnosis, Postpones Shows

    02:51
  • FDA Approves Pill Version of Wegovy: What You Need to Know

    03:23
  • Flu Cases Surge Nationwide as Families Gather for Holidays

    02:23
  • Feeling Overwhelmed by the Holidays? How to Manage Stress

    05:43
  • How to Protect Yourself as Flu and Whooping Cough Cases Surge

    03:56
  • James Van Der Beek Opens Up to TODAY About Cancer Battle

    06:42
  • New HHS rules target care for transgender minors

    02:22
  • Trump signs executive order to fast-track reclassification of cannabis

    01:16
  • House Passes GOP Healthcare Bill Without Subsidy Extension

    02:17
  • Flu Case Numbers Spike Across US as the Holidays Approach

    04:13
  • Whooping cough cases surge nationwide as vaccinations drop

    02:29
  • How to Protect Yourself as Cold and Flu Season Ramps Up

    03:44
  • FDA Sends Warning to Retailers Selling Recalled Baby Formula

    00:33
  • How to Reframe the Way We Talk and Think About Menopause

    05:17
  • Can Lawmakers Find a Solution to Expiring Health Care Subsidies?

    05:04
  • King Charles says his cancer treatment will be scaled back

    02:08
  • Many Obamacare premiums expected to spike after votes on health care plans fail

    02:15
  • Surrogacy company suddenly shuts down, leaving families and surrogates in limbo

    02:35
  • Is the K-Beauty Trend Really Worth All the Hype?

    04:37

Nightly News

FDA approves first medical treatment for Alzheimer’s in 18 years

NBC News Clone summarizes the latest on: Fda Approves First Medical Treatment For Alzheimer S In 18 Years 114445381880 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.

01:30

The drug aducanumab, developed by the company Biogen, attacks the amyloid protein that builds up in the brain of Alzheimer’s patients. The drug is going on the market even though the FDA says there are “uncertainties regarding clinical benefits” and is requiring Biogen to do another clinical trial.

×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone